EHA2026 spotlights Caribou Biosciences advances in allogeneic CAR-T treatments for lymphoma and multiple myeloma

Traders Union
All News
Companies
Caribou Biosciences reveals CAR-T progress

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Market Voices

Companies

Ivan Andriyenko

12.05.2026

EHA2026 spotlights Caribou Biosciences advances in allogeneic CAR-T treatments for lymphoma and multiple myeloma — Caribou Biosciences reveals CAR-T progress

Caribou Biosciences announced that it will deliver two oral presentations at EHA2026 to reveal advancements in its allogeneic CAR-T cell therapy programs for blood cancers.

The presentations will cover vispa-cel, targeted at lymphoma, and CB-011, aimed at patients with multiple myeloma. These programs leverage CRISPR technology in cell therapy development, reflecting Caribou Biosciences’ ongoing push to expand novel treatment options for hematological malignancies.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Caribou Biosciences CEO Rachel Haurwitz recently participated in a BofA Securities Health Care Conference in Las Vegas to discuss advances in the company’s biotech pipeline. Haurwitz also joined a Bank of America fireside chat webcast focused on the latest developments in cell therapy. These appearances follow ongoing company efforts to highlight progress in its CRISPR-based therapies.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

Tokenized stocks in the spotlight: How do they work and are they worth trading?

By Mikhail Vnuchkov
9 hours ago

Tokenized stocks in the spotlight: How do they work and are they worth trading?

Editors' Picks

Do politicians make the best stock traders?

By Ciaran Ryan
Yesterday

Do politicians make the best stock traders?

Editors' Picks

Crypto test drive: How automakers are exploring digital assets

By Anastasiia Chabaniuk
14.07.2026

Crypto test drive: How automakers are exploring digital assets

Editors' Picks

All Editors' Top Picks

Latest Caribou News

Longer-term CB-011 results unveiled by Caribou Biosciences at EHA2026

By Elena Nikulina
14.06.2026

Longer-term CB-011 results unveiled by Caribou Biosciences at EHA2026

Companies

Caribou Biosciences presents new data on allogeneic CAR-T cell programs at EHA

By Olga Shendetskaya
12.06.2026

Caribou Biosciences presents new data on allogeneic CAR-T cell programs at EHA

Companies

CB-011 dose escalation data points to advances in relapsed multiple myeloma, Caribou Biosciences launches study update

By Eugene Komchuk
11.06.2026

CB-011 dose escalation data points to advances in relapsed multiple myeloma, Caribou Biosciences launches study update

Companies

All Caribou News

Mikhail Vnuchkov
9 hours ago

Tokenized stocks in the spotlight: How do they work and are they worth trading?

Ciaran Ryan
Yesterday

Do politicians make the best stock traders?

Anastasiia Chabaniuk
14.07.2026

Crypto test drive: How automakers are exploring digital assets

Mikhail Vnuchkov
13.07.2026

Lindsey Graham death: U.S. senator’s crypto legacy

Pavlo Kot
12.07.2026

Tether under pressure: USDT in Europe, audit questions, and the fight for trust

Dmytro Kharkov
2 min ago

SpaceX stock falls back to opening price, Michael Shermer notes

Artem Shendetskii
47 min ago

Trillions of dollars are at stake as parties endure, Brian Sullivan notes

Elena Nikulina
1 hour ago

Copper market resists downside despite sell signals, Linda Raschke notes

Anastasiia Chabaniuk
1 hour ago

Michael A. Gayed: Portfolio strategy should adapt to changing market conditions

Hanna Syniavska
1 hour ago

Nick Tomaino: Crypto marketing must balance authenticity and community appeal

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Olga Shendetskaya
5 min ago

U.S.-Iran conflict widens as Hormuz shipping traffic falls

U.S.-Iran conflict widens as Hormuz shipping traffic falls

Andrey Mastykin
2 hours ago

TSMC plans bigger Arizona investment after record profit

TSMC plans bigger Arizona investment after record profit

Olga Shendetskaya
5 hours ago

Nvidia deepens Japan push as robotics becomes next AI frontier

Nvidia deepens Japan push as robotics becomes next AI frontier

Ivan Andriyenko
5 hours ago

Samsung and SK Hynix tumble as tech selloff hits Asia

Samsung and SK Hynix tumble as tech selloff hits Asia

Igor Krasulya
6 hours ago

Oil eases after rally as Iran tensions keep supply risks alive

Oil eases after rally as Iran tensions keep supply risks alive

Top 5 companies for you

United States

Live News

Anton Kharitonov
Now

Alphabet extends recovery as AI execution restores investor confidence

Anton Kharitonov
Now

Microsoft rebounds as AI innovation and easing inflation improve sentiment

Anton Kharitonov
Now

Apple breaks above resistance as China AI approval boosts momentum

Anton Kharitonov
Now

Bitcoin pauses below resistance as macro optimism meets geopolitical uncertainty

Mykhailo Ihnatenko
Now

IBM stock struggles to recover after record decline

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.